Average Co-Inventor Count = 1.94
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pharmacia Aktiebolag (6 from 34 patents)
2. Kabi Pharmacia Ab (6 from 27 patents)
3. Pharmacia Ab (3 from 184 patents)
4. Synphora Ab (3 from 4 patents)
5. Pharmacia & Upjohn Aktiebolag (2 from 47 patents)
6. Pharmacia & Upjohn Ab (1 from 76 patents)
7. Kabi Pharmacia (1 from 2 patents)
8. Synphra Ab (1 from 1 patent)
9. Pfizer Health Ab (7 patents)
23 patents:
1. 7163959 - Prostagladin derivatives for the treatment of glaucoma or ocular hypertension
2. 6562868 - Method for treatment of female sexual dysfunction
3. 6495563 - Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
4. 6476074 - Method and composition for treatment of erectile dysfunction
5. 6429226 - Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
6. 6417230 - Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
7. 6187813 - Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
8. 6030999 - Prostaglandin derivatives for the treatment of glaucoma or ocular
9. 6031001 - Use of prostaglandins
10. 5849791 - Prostaglandin derivatives for the treatment of glaucoma or ocular
11. 5773472 - Method and means for prevention of cataract
12. 5760075 - Method and means for prevention and treatment of secondary cataract
13. 5627208 - Prostaglandin derivatives for the treatment of glaucoma or ocular
14. 5578618 - Prostaglandin derivatives for the treatment of glaucoma or ocular
15. 5516796 - Thioprostaglandins and -prostaglandin-like compounds and therapeutic